Skip to main content

Table 4 Comparison of anthropometric, clinical and densitometric variables between patients with AS with and without sarcopenia according to EWGSOP definition

From: Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

 

AS patients with sarcopenia N = 23

AS patients without sarcopenia N = 44

P

Age (yrs): m (SD)

42.3 (11.6)

40.1 (10.7)

NS

Height (m): m (SD)

1.71 (0.06)

1.73 (0.06)

NS

Weight (kg): m (SD)

64.6 (11.0)

77.9 (11.9)

<0.0001

BMI (kg/m2): m (SD)

21.6 (3.6)

25.7 (3.7)

<0.0001

Disease duration (yrs): m (SD)

11.6 (9.1)

8.6 (6.6)

NS

Lumbar spine BMD (g/cm2): m (SD)

1.092 (0.23)

1.134 (0.14)

NS

Lumbar spine T-score: m (SD)

−0.97 (3.4)

−0.47 (1.2)

0.032

Total hip BMD (g/cm2): m (SD)

0.914 (0.13)

1.006 (0.23)

0.017

Total hipT-score: m (SD)

−0.96 (1.4)

−0.35 (1.1)

0.017

Osteoporosis: n (%)

7 (30.4)

4 (9.1)

0.038

BASDAI (0–10): m (SD)

4.4 (2.4)

3.4 (2.5)

0.002

BASMI (0–10): m (SD)

2.9 (2.2)

2.7 (2.7)

NS

BASFI (0–100): m (SD)

44.5 (26.5)

38.0 (25.5)

NS

BAS-G (0–100): m (SD)

19.7 (16.8)

16.1 (22.6)

NS

Hand grip strength (kg): m (SD)

19.5 (7.0)

25.3 (9.8)

NS

Timed get-up-and-go test (sec) < 10 sec: n (%)

14 (66.7)

33 (75.0)

NS

Arm circumference (cm): m (SD)

26.8 (1.9)

30.5 (3.9)

0.002

Waist circumference (cm): m (SD)

85.7 (10.8)

94.1 (11.4)

<0.0001

MNA test (0–17): m (SD)

0.34 (0.4)

0.19 (0.3)

NS

SASSS (0–72): m (SD)

14.3 (18.7)

9.5 (14.6)

NS

CRP (mg/l): m (SD)

21.8 (10.1)

11.6 (10.1)

NS

ESR (mm/H): m (SD)

31.0 (22.3)

24.2 (18.4)

NS

Patients taking TNFi: n (%)

11 (33.3)

11 (32.4)

NS

  1. BMI body mass index, CRP C-reactive protein, ESR erythrocyte sedimentation rate, MNA Mini Nutritional Assessment, SASSS Stoke Ankylosing Spondylitis Spinal Score